Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia.

Meier-Stephenson V, Riemer J, Narendran A.

Onco Targets Ther. 2017 May 16;10:2581-2593. doi: 10.2147/OTT.S136484. eCollection 2017.

2.

The emergence and evolution of the research fronts in HIV/AIDS research.

Fajardo-Ortiz D, Lopez-Cervantes M, Duran L, Dumontier M, Lara M, Ochoa H, Castano VM.

PLoS One. 2017 May 25;12(5):e0178293. doi: 10.1371/journal.pone.0178293. eCollection 2017.

3.

Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders.

Zhang L, Jia X, Jin JO, Lu H, Tan Z.

Genomics Proteomics Bioinformatics. 2017 Apr;15(2):110-120. doi: 10.1016/j.gpb.2016.11.002. Epub 2017 Apr 6. Review.

4.

Behavioural traits propagate across generations via segregated iterative-somatic and gametic epigenetic mechanisms.

Mitchell E, Klein SL, Argyropoulos KV, Sharma A, Chan RB, Toth JG, Barboza L, Bavley C, Bortolozzi A, Chen Q, Liu B, Ingenito J, Mark W, Dudakov J, Gross S, Di Paolo G, Artigas F, van den Brink M, Toth M.

Nat Commun. 2016 May 13;7:11492. doi: 10.1038/ncomms11492.

5.

A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2.

Mi Z, Ding J, Zhang Q, Zhao J, Ma L, Yu H, Liu Z, Shan G, Li X, Zhou J, Wei T, Zhang L, Guo F, Liang C, Cen S.

Sci Rep. 2015 Dec 16;5:18499. doi: 10.1038/srep18499.

6.

HIV-1 and Human PEG10 Frameshift Elements Are Functionally Distinct and Distinguished by Novel Small Molecule Modulators.

Cardno TS, Shimaki Y, Sleebs BE, Lackovic K, Parisot JP, Moss RM, Crowe-McAuliffe C, Mathew SF, Edgar CD, Kleffmann T, Tate WP.

PLoS One. 2015 Oct 8;10(10):e0139036. doi: 10.1371/journal.pone.0139036. eCollection 2015.

7.
8.

De-novo design, synthesis and evaluation of novel 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as HIV-1 reverse transcriptase inhibitors.

Chander S, Ashok P, Singh A, Murugesan S.

Chem Cent J. 2015 Jun 9;9:33. doi: 10.1186/s13065-015-0111-6. eCollection 2015.

9.

Proteomics in the investigation of HIV-1 interactions with host proteins.

Li M.

Proteomics Clin Appl. 2015 Feb;9(1-2):221-34. doi: 10.1002/prca.201400101. Epub 2015 Jan 19. Review.

10.

Identification of a novel type of small molecule inhibitor against HIV-1.

Kim BS, Park JA, Kim MJ, Kim SH, Yu KL, You JC.

BMB Rep. 2015 Feb;48(2):121-6.

11.

Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Gable JE, Acker TM, Craik CS.

Chem Rev. 2014 Nov 26;114(22):11382-412. doi: 10.1021/cr500255e. Epub 2014 Oct 2. Review. No abstract available.

12.

An allosteric modulator of HIV-1 protease shows equipotent inhibition of wild-type and drug-resistant proteases.

Ung PM, Dunbar JB Jr, Gestwicki JE, Carlson HA.

J Med Chem. 2014 Aug 14;57(15):6468-78. doi: 10.1021/jm5008352. Epub 2014 Aug 1.

13.

A high throughput RNAi screen reveals determinants of HIV-1 activity in host kinases.

Jiang WM, Zhang XY, Zhang YZ, Liu L, Lu HZ.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2229-37. eCollection 2014.

14.

Pokeweed antiviral protein alters splicing of HIV-1 RNAs, resulting in reduced virus production.

Zhabokritsky A, Mansouri S, Hudak KA.

RNA. 2014 Aug;20(8):1238-47. doi: 10.1261/rna.043141.113. Epub 2014 Jun 20.

15.

HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods.

Quy VC, Pantano S, Rossetti G, Giacca M, Carloni P.

Biology (Basel). 2012 Aug 13;1(2):277-96. doi: 10.3390/biology1020277.

16.

Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.

Fofana MO, Knight GM, Gomez GB, White RG, Dowdy DW.

PLoS One. 2014 May 9;9(5):e96389. doi: 10.1371/journal.pone.0096389. eCollection 2014.

17.

The HCV Revolution Did Not Happen Overnight.

Kwong AD.

ACS Med Chem Lett. 2014 Mar 13;5(3):214-220.

18.

Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody.

Lülf S, Matz J, Rouyez MC, Järviluoma A, Saksela K, Benichou S, Geyer M.

Retrovirology. 2014 Mar 13;11:24. doi: 10.1186/1742-4690-11-24.

19.

Clinically relevant drug-drug interactions between antiretrovirals and antifungals.

Vadlapatla RK, Patel M, Paturi DK, Pal D, Mitra AK.

Expert Opin Drug Metab Toxicol. 2014 Apr;10(4):561-80. doi: 10.1517/17425255.2014.883379. Epub 2014 Feb 12. Review.

20.

HIV-1 Protease and Substrate Coevolution Validates the Substrate Envelope As the Substrate Recognition Pattern.

Ozen A, Haliloğlu T, Schiffer CA.

J Chem Theory Comput. 2012 Feb 14;8(2). doi: 10.1021/ct200668a.

Supplemental Content

Support Center